Ublituximab Is Associated With Significant Improvement in the Multiple Sclerosis Functional Composite (MSFC): Results From the Phase 3 ULTIMATE I & II Studies

Drug Category : Array
Conference Category : Array
Lead Author : Steinman L, et al.
Published Date : 14/10/2021
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2021/10/Steinman-LB-ECTRIMS-2021-PH3-ULTIMATE-I-II.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top